Do newer types of biologics increase the risk of MACE and VTE more than older TNFs in patients with psoriasis or psoriatic arthritis? Share on Facebook. Opens in a new tab or window Share on Bluesky.

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate ... Data taken from [38]. Table 5. Total cost of care per patient per year ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

The 2024-25 Premier League table is tight from top to bottom as another season of chaos approaches its climax. [ MORE: Premier League 2024-25 schedule, how to watch live] There are so many big ...

Biological sciences encompasses all the divisions of natural sciences examining various aspects of vital processes. The concept includes anatomy, physiology, cell biology, biochemistry and ...

Oblique line scan microscopy achieves nanoscale spatial and sub-millisecond temporal resolution across a large field of view, enabling improved and robust single-molecule biophysical measurements ...

Feb. 11, 2025 — A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are ... 'Junk' RNA Segments Play ...

Biologics are incredibly powerful and targeted ... but many are in development phase. Table 1 summarises some of the clinical trials of different long-acting technologies for delivery of proteins ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Objective This observational cohort study investigated the impact of biological (b) disease-modifying antirheumatic drugs (DMARDs) on the outcomes of serious infections (SIs) in patients with ...